EFSA Negates Future Health Claims for Probiotics
The European Food Safety Authority (EFSA; Parma, Italy) has no displayed interest in drafting health claims for probiotics, according to accounts from EFSA’s June 15 health claims summit reported by NutraIngredients.com.One hundred and twenty representatives of the probiotics industry met in Brussels for a Q&A session which was the first opportunity for industry leaders to meet with EFSA since the organization enacted new health claims regulations three years ago.
The European Food Safety Authority (EFSA; Parma, Italy) has no displayed interest in drafting health claims for probiotics, according to accounts from EFSA’s June 15 health claims summit reported by NutraIngredients.com.
One hundred and twenty representatives of the probiotics industry met in Brussels for a Q&A session which was the first opportunity for industry leaders to meet with EFSA since the organization enacted new health claims regulations three years ago.
EFSA responded negatively when asked if it would draft guidance for probiotics like those recently produced by the Canadian regulatory authority. The Canadian regulatory authority released health claims guidance for safety, quality, and labeling aspects of foods containing probiotics. EFSA has not issued health claims on any food groups.
Full disclosure of questions and answers posed at the EFSA summit has not been made public, but EFSA reportedly told NutraIngredients.com on July 2 that it would publish an “overview” and report on the meeting in autumn.
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
